Entecavir monohydrate

Entecavir monohydrate
Product Description

Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes entecavir monohydrate. It belongs to anti-viral category. Contact us for more information.

  • Status: DMF No.:031949
  • Patent Expiration: Off-patent
  • Usage:AntiHBV

Read more Show less

BrightGene Bio-Medical Technology Co.,Ltd.

  • CN
  • 2015
    On CPHI since
View company profile
Specifications
  • CAS Registry Number
    209216-23-9
  • Selling Points
    Quality Service
  • Supplied from
    China
More specifications Fewer specifications
Sales Markets
Show more Show less

BrightGene Bio-Medical Technology Co.,Ltd.

  • CN
  • 2015
    On CPHI since
View company profile

More Products from BrightGene Bio-Medical Technology Co.,Ltd. (49)

  • Everolimus（without BHT）

    Product Everolimus（without BHT）

    • Status: MF No.: 230MF10023 • Patent Expiration: Off-patent • Usage: Oncology
  • Midostaurin

    Product Midostaurin

    • Status: Validated • Patent Expiration: Off-patent • Usage: Oncology
  • Fondaparinux Sodium

    Product Fondaparinux Sodium

    • Status: DMF No. :030767 • Patent Expiration: Off-patent • Usage:Anticoagulant
  • Anidulafungin

    Product Anidulafungin

    Status:
    DMF No.: 032010                                              
    ASMF Approved
    Patent Expiration: Off-patentUsage: Antifungal
  • Argatroban Monohydrate

    Product Argatroban Monohydrate

    • Status: MF No.: 230MF10028; USDMF to be filed in Q4,2020 • Patent Expiration: Off-patent • Usage:Anticoagulant
  • Caspofungin Acetate

    Product Caspofungin Acetate

    • Status: ASMF Approved & DMF No.:034091 • Patent Expiration:Off-patent • Usage:Antifungal
  • Eribulin Mesilate

    Product Eribulin Mesilate

    • Status: Validated • Patent Expiration: US：2023.07.20 ；CN：off-patent • Usage: Oncology
  • Everolimus(2.0% BHT)

    Product Everolimus(2.0% BHT)

    • Status: DMF No.:032020 • Patent Expiration: Off-patent • Usage: Oncology
  • Fidaxomicin

    Product Fidaxomicin

    • Status: DMF No.: 028803 • Patent Expiration: US：2027.03.04; • Usage: Anti-infection
  • Fondaparinux Sodium

    Product Fondaparinux Sodium

    Brightgene Bio-Medical Technology Co.Ltd. Offers a wide range of anti-infective products which includes fondaparinux sodium. It belongs to cardiovascular category. Contact us for more information.
  • Micafungin Sodium

    Product Micafungin Sodium

    • Status:  • DMF No.:031449 • ASMF Approved • MF No.: 230MF10169 • Patent Expiration: Off-patent • Usage:Antifungal
  • Posaconazole Amorphous

    Product Posaconazole Amorphous

    • Status: DMF No.: 028314 • Patent Expiration: Off-patent • Usage: Antifungal
show all 49 other products